2021
DOI: 10.1016/j.jddst.2021.102822
|View full text |Cite
|
Sign up to set email alerts
|

Impact of phospholipids, surfactants and cholesterol selection on the performance of transfersomes vesicles using medical nebulizers for pulmonary drug delivery

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

3
27
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 33 publications
(30 citation statements)
references
References 53 publications
3
27
0
Order By: Relevance
“…The presence of the charge may be advantageous in maintaining the formulation’s stability as electrostatic repulsive forces reduce the chances of particle aggregation. It has also been reported that a mild surface charge may be related to the presence of impurities in the lipids [ 14 , 15 ]. The results of zeta potential, particle size, and polydispersity index are shown in Table 1 .…”
Section: Resultsmentioning
confidence: 99%
“…The presence of the charge may be advantageous in maintaining the formulation’s stability as electrostatic repulsive forces reduce the chances of particle aggregation. It has also been reported that a mild surface charge may be related to the presence of impurities in the lipids [ 14 , 15 ]. The results of zeta potential, particle size, and polydispersity index are shown in Table 1 .…”
Section: Resultsmentioning
confidence: 99%
“…However, TW80AATG and SDCAATG did not exhibit any decrease in the AA content after storage at 40 °C for 3 months. According to the literature, the hydrophilic edge activator could cover the surface of vesicles more because of their larger hydrophilic moiety, which leads to a reduction in interfacial tension of the vesicles and a subsequent improvement in vesicular integrity [ 47 ]. Therefore, TW80 and SDC may facilitate the stability of the formulation because of their higher HLB values.…”
Section: Resultsmentioning
confidence: 99%
“…It is one of the components used in the preparation of lipid nanoparticles that fill the gaps between the phospholipids of the lipid bilayer. 70 It also promotes the fusion of nanoparticles with the cell membrane. 71 The structures of the various lipid components used in lipid nanoparticles are presented in Figure 3.…”
Section: Lipid-based Nanocarriers For Diabeticmentioning
confidence: 99%